Cargando…
Immunization of rabbits with synthetic peptides derived from a highly conserved β-sheet epitope region underneath the receptor binding site of influenza A virus
BACKGROUND: There is increasing concern about the speed with which health care providers can administer prophylaxis and treatment in an influenza pandemic. Generally, it takes several months to manufacture an influenza vaccine by propagation of the virus in chicken eggs or cultured cells. Newer, fas...
Autores principales: | Ideno, Shoji, Sakai, Kaoru, Yunoki, Mikihiro, Kubota-Koketsu, Ritsuko, Inoue, Yuji, Nakamura, Shota, Yasunaga, Teruo, Okuno, Yoshinobu, Ikuta, Kazuyoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3821756/ https://www.ncbi.nlm.nih.gov/pubmed/24235814 http://dx.doi.org/10.2147/BTT.S50870 |
Ejemplares similares
-
Significant neutralizing activities against H2N2 influenza A viruses
in human intravenous immunoglobulin lots manufactured from 1993 to
2010
por: Kubota-Koketsu, Ritsuko, et al.
Publicado: (2012) -
Virus Neutralization by Human Intravenous Immunoglobulin Against Influenza Virus Subtypes A/H5 and A/H7
por: Kubota-Koketsu, Ritsuko, et al.
Publicado: (2021) -
Broad neutralizing human monoclonal antibodies against influenza virus from vaccinated healthy donors
por: Kubota-Koketsu, Ritsuko, et al.
Publicado: (2009) -
Neutralizing activities of human immunoglobulin derived from donors in Japan against mosquito-borne flaviviruses, Japanese encephalitis virus, West Nile virus, and dengue virus
por: Yunoki, Mikihiro, et al.
Publicado: (2016) -
Significant neutralizing activity of human immunoglobulin preparations against pandemic 2009 H1N1
por: Yunoki, Mikihiro, et al.
Publicado: (2010)